Fabrice Lejeune
Lille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
The Expanding Landscape of Nonsense-Mediated mRNA Decay.
Journal: Journal of molecular biology
Published: August 04, 2026
Comparative evaluation of TRIDs : a strategy to improve treatments.
Journal: Journal of translational medicine
Published: February 17, 2026
Screening Methods for NMD Inhibitors or Readthrough Activators.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: July 23, 2025
Exploring the role of readthrough-inducing molecule 2,6-diaminopurine to increase immune response against cancer cells.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 27, 2025
Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 28, 2023
Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System.
Journal: Biomedicines
Published: September 18, 2023
Nonsense-mediated mRNA decay, a simplified view of a complex mechanism.
Journal: BMB reports
Published: September 15, 2023
Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot-Marie-Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 26, 2023
Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 25, 2022
Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism.
Journal: Biomedicines
Published: December 14, 2021
A role for AKT1 in nonsense-mediated mRNA decay.
Journal: Nucleic acids research
Published: February 14, 2021
Last Updated: 09/26/2026